BIOECLIPSE

BioEclipse Therapeutics™ is a clinical-stage oncology company that uses its proprietary platform technology to develop the next generation of immuno-oncology therapeutics... BioEclipse Therapeutics was founded as ConcentRx Inc. and was renamed in 2017, concomitant with launching our clinical strategy, with new funding and the build out of an experienced executive team and an independent Board of Directors. Our Board of Directors is now made up of life science company investors, and biopharmaceutical executives with product development and commercial expertise.

Also known as: BioEclipse Therapeutics™

Primary location: Mountain View United States